AbbVie mishandles Humira death complaints: FDA by Angus Liu Monday, June 11, 2018 FDA inspectors found that AbbVie didn’t include historical death complaints for the same lot in its search system for its all-too-important drug Humira.
AbbVie's Humira, Merck's Keytruda and more: Top 10 drugs of 2024 by Eric Sagonowsky Thursday, June 7, 2018 Blockbusters Humira and Keytruda will lead 2024 sales, according to an EvaluatePharma report, joined by new Sanofi launch Dupixent.
After Abbvie's usual first, Sunovion's a new second in TV spend by Beth Snyder Bulik Wednesday, June 6, 2018 AbbVie's Humira held on to its ad spending crown yet again in May, but Sunovion's Latuda jumped up to knock Pfizer's Lyrica out of second place.
Top 10 best-selling drugs by 25 years of U.S. sales by Angus Liu Monday, May 14, 2018 What's notable about the 10 best-selling drugs over the past 25 years? Here's a hint: Today's king is passing, and the next has a long life ahead.
AbbVie, Pfizer are becoming an item atop the ad-spend charts by Beth Snyder Bulik Wednesday, May 2, 2018 AbbVie's Humira and Pfizer's Lyrica once again rank No. 1 and No. 2 on our April list for pharma TV ad spending, according to iSpot.tv data.
Biogen to boost stake in biosims joint venture: CFO by Eric Sagonowsky Friday, April 27, 2018 Ahead of a big launch this fall, Biogen says it plans to increase its stake in a biosimilars joint venture shared with Samsung.
Novartis CEO calls for simpler biosim rules, end to rebate wall by Eric Sagonowsky Friday, April 13, 2018 Novartis CEO Vas Narasimhan has joined the chorus calling for the U.S. to step up on biosimilar market access, stat.
FiercePharmaAsia—Novartis, Samsung Bioepis, Takeda and more by Angus Liu Friday, April 13, 2018 Novartis faces doctor kickback allegations in China, Samsung and AbbVie ink a Humira biosim settlement, and Takeda seeks financing for a Shire bid.
No March madness for pharma ad spending as Humira tops list by Beth Snyder Bulik Wednesday, April 11, 2018 AbbVie’s Humira and Pfizer’s Lyrica remained in the top two spots for pharma TV ad spending in March, according to realtime TV ad tracker iSpot.tv.
